Granules Pharmaceuticals Inc.June 27, 2025

FDA 483 - Granules Pharmaceuticals Inc. - June 27, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Granules Pharmaceuticals Inc.

Record Details

An FDA inspection of Granules Pharmaceuticals Inc. in Chantilly, VA, revealed a significant concern regarding data integrity and control over computer systems. The firm's QC laboratory personnel were found to be using shared login credentials for analytical testing systems, preventing individual accountability. Additionally, users had the ability to alter system date and time settings on laboratory computers, indicating a lack of appropriate controls.

Company: Granules Pharmaceuticals Inc.
Inspection Date: June 27, 2025
Product Type: Drugs
Office: Office of Regulatory Affairs
People: David A. Oluwo (Pharmacy Intern/Certified Pharmacy Technician)
Kara J. Wright

Open in Dashboard

ID · 903c5e10-6a83-4038-a7fa-4a6b00d240b1